Linda Yaccarino, a prominent figure in the media industry, has been appointed as the new CEO of EMed, a company focused on ...

GLP-1 drugs have shifted from medical to mainstream, and the impact is rippling far beyond health. From luxury to lifestyle, ...

Linda Yaccarino, former CEO of X (formerly Twitter) and ex-NBCUniversal ad exec, has reappeared as the CEO of eMed Population ...

Propel Health Communications, a 2025 MM+M Agency 100 honoree, hired Christopher Thorn as SVP, creative director and Lauren ...

Former X CEO Linda Yaccarino has been tapped as the new CEO of eMed Population Health, an AI‑driven health tech startup.

Yaccarino, who has a house in Woodbury, graduated from Deer Park High in 1981 with her twin sister, Lori. Both were elected ...

Even though Novo Nordisk warned that copycat versions of its obesity and diabetes drugs would hurt sales in the U.S., second-quarter sales saw a 67% rise year on year. More news covers telehealth ...

There is an opportunity to combine technology, lifestyle, and data in a new powerful way through the digital channels that ...

Despite not coming from a healthcare background, Yaccarino brings over a decade of experience in digital revenue and brand ...

Linda Yaccarino’s experience will be instrumental in developing innovative programs focusing on the future of peptide ...

Yaccarino will be CEO of a unit at the company, which focuses on patients taking weight-management and diabetes medications.